← Back to Search

MRI

MRI 1.5T and 3.0T for Kidney Transplant

N/A

Waitlist Available

Led By Lilach Lerman, MD, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial looks to see if a certain MRI method can be used to tell if someone who's had a kidney transplant has fibrosis.

Eligible Conditions

Kidney Transplant

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The values and correlation of f with IF

Secondary outcome measures

The correlation of f with renal function attributes and pro-fibrogenic activity

Trial Design

2Treatment groups

Experimental Treatment

Group I: 7 years after kidney transplantationExperimental Treatment1 Intervention

Patients 7 years after KT (N=10); 5 patients with eGFR ≤35 mL/min/1.73m2, and 5 with eGFR>35 mL/min/1.73m2.

Group II: 4 years after kidney transplantationExperimental Treatment1 Intervention

Patients 4 years after KT (N=10); 5 with estimated (e) glomerular filtration rate (GFR) ≤35 mL/min/1.73m2, and 5 with estimated (e) glomerular filtration rate (GFR)>35 mL/min/1.73m2.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,207 Previous Clinical Trials

3,767,118 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,671 Previous Clinical Trials

28,017,041 Total Patients Enrolled

Lilach Lerman, MD, PhDPrincipal InvestigatorMayo Clinic

Media Library

MRI 1.5T and 3.0T (MRI) Clinical Trial Eligibility Overview. Trial Name: NCT04899167 — N/A

Kidney Transplant Research Study Groups: 4 years after kidney transplantation, 7 years after kidney transplantation

Kidney Transplant Clinical Trial 2023: MRI 1.5T and 3.0T Highlights & Side Effects. Trial Name: NCT04899167 — N/A

MRI 1.5T and 3.0T (MRI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04899167 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age requirement for this research study limited to participants under 30?

"This clinical trial has an age range of 18 to 80 as its inclusion criteria. There are 85 studies dedicated to those under 18 and 438 trials for the elderly population over 65 years old."

Answered by AI

Is participation in this experiment still available to people seeking treatment?

"The information found on clinicaltrials.gov shows that this particular research project is not actively recruiting patients. The trial was initially posted back in August 2021 and the last update occurred in February 2022. Though enrolment has been paused, there are 479 other medical studies currently looking for volunteers."

Answered by AI

To whom is this clinical trial open for participation?

"Up to 20 adults, aged 18-80 years of age and living with fibrosis, are being recruited for this clinical trial. To participate they must have received a donor kidney transplant within the last 4 or 7 years, be cognitively capable of providing written informed consent and adhere to protocol requirements."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Noninvasive Evaluation of Renal Allograft Fibrosis by MRI

Lilach O Lerman 2021. "Noninvasive Evaluation of Renal Allograft Fibrosis by MRI". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04899167.